Impact of iron fortification on the geospatial patterns of malaria and non-malaria infection risk among young children: a secondary spatial analysis of clinical trial data from Ghana. by Aimone, Ashley M et al.
Aimone, Ashley M; Brown, Patrick; Owusu-Agyei, Seth; Zlotkin,
Stanley H; Cole, Donald C (2017) Impact of iron fortification on the
geospatial patterns of malaria and non-malaria infection risk among
young children: a secondary spatial analysis of clinical trial data
from Ghana. BMJ open, 7 (5). e013192-. ISSN 2044-6055 DOI:
https://doi.org/10.1136/bmjopen-2016-013192
Downloaded from: http://researchonline.lshtm.ac.uk/4651385/
DOI: 10.1136/bmjopen-2016-013192
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/3.0/
 1Aimone AM, et al. BMJ Open 2017;7:e013192. doi:10.1136/bmjopen-2016-013192
Open Access 
AbstrAct
Objectives Patterns of infection among children with 
varying levels of iron status in a malaria endemic area 
may vary spatially in ways requiring integrated infection 
and iron deficiency control programmes. The objective of 
this secondary analysis was to determine the geospatial 
factors associated with malaria and non-malaria infection 
status among young Ghanaian children at the end of a 
5-month iron intervention trial.
Design Cluster-randomised controlled trial.
Setting Rural Ghana
Participants 1943 children (6–35 months of age) with 
geocoded compounds.
Interventions Point-of-use fortification with micronutrient 
powders containing vitamins and minerals with or without 
iron.
Primary and secondary outcome measures Generalised 
linear geostatistical models with a Matern spatial 
correlation function were used to analyse four infection 
response variables, defined using different combinations 
of inflammation (C-reactive protein, CRP >5 mg/L) and 
malaria parasitaemia. Analyses were also stratified by 
treatment group to assess the independent effects of the 
iron intervention.
Results The by-group and combined-group analyses 
both showed that baseline infection status was the most 
consistent predictor of endline infection risk, particularly 
when infection was defined using parasitaemia. In the 
No-iron group, age above 24 months and weight-for-
length z-score at baseline were associated with high 
CRP at endline. Higher asset score was associated with 
a 12% decreased odds of endline infection, defined as 
CRP >5 mg/L and/or parasitaemia (OR 0.88, 95% credible 
interval 0.78 to 0.98), regardless of group. Maps of the 
predicted risk and spatial random effects showed a 
defined low-risk area around the District centre, regardless 
of how infection was defined.
Conclusion In a clinical trial setting of iron fortification, 
where all children receive treated bed nets and access to 
malaria treatment, there may be geographical variation 
in the risk of infection with distinct high-risk and low-risk 
areas, particularly around municipal centres.
Trial registration number  clinicaltrials. gov, 
NCT01001871.
Background
The leading causes of death in children less 
than 5 years of age are infection related, 
and child mortality rates are highest in 
low-income and middle-income coun-
tries (LMICs).1 Malnutrition is also a large 
contributor to mortality (45% of all deaths),1 
including micronutrient deficiencies. The 
most common nutritional disorder world-
wide is iron deficiency,2 which is estimated to 
account for 2.2 million disability-adjusted life 
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Research
Strengths and limitations of this study
 ► The geostatistical analyses conducted in this 
study are the first of their kind to use model-based 
geostatistics with Bayesian inference and integrated 
nested Laplace approximations to explore the spatial 
variation and associated risk factors of malaria and 
non-malaria infection risk among children in rural 
Ghana after a 5-month randomised iron intervention 
trial.
 ► These analyses also provide input into the potential 
utility of geographical indicators, particularly for 
assessing infection risk potential, which could help 
guide the implementation of iron interventions in 
areas where infectious diseases are prevalent.
 ► Since satellite-derived spatial data often vary at a 
higher level than the individual (eg, village or region), 
the use of these data in statistical models with 
individual-level outcomes may increase the risk of 
a change of support or ecological inference problem.
 ► The use of C-reactive protein (CRP) as an indicator 
of non-malaria infection may have led to the 
underestimation of this outcome, since CRP is an 
acute phase protein that only rises in accordance 
with the first 48 hours of the inflammatory response.
 ► Straight-line distance, rather than distance by road, 
was used to estimate proximity to a health facility 
or the district centre, and thus may not have fully 
accounted for travel impedance.
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years lost per year among children less than 5 years of 
age.3 While iron deficient children are more vulnerable 
to infections (primarily due to compromised immune 
function),4 5 infection and inflammation can also affect 
iron homeostasis6 and the risk of iron deficiency.7 Iron 
status can usually be improved through food fortifica-
tion or supplementation; however, evidence from a large 
randomised trial conducted in a malaria endemic area 
(Pemba, Zanzibar) indicated that supplementing young 
children with iron may increase their risk of malaria and 
infection-related morbidity and mortality, particularly if 
they are iron replete.8 Since iron supplements or fortifi-
cants would likely be withheld from children with malaria 
or other infections, assessing the risk of infection is an 
important component of developing safe and effective 
means of administering iron to children in LMICs.
Measuring biomarkers of infection status (such as C-re-
active protein, CRP) among children in a low-resource 
context may have limited feasibility, due to the require-
ment of blood samples, and the potential for inflammation 
prevalence to vary over relatively short periods of time (eg, 
within seasons). As such, there is a need to identify indi-
cators or risk factors associated with infection in LMICs 
that are more feasible to measure, and thus provide an 
efficient means of identifying high-risk populations. This 
need could be addressed with geographical factors (or 
‘geo-indicators’), such as the environmental or spatial 
characteristics of a village or region.9 Geo-indicators 
could provide additional insight into the dynamics and 
distribution of infection among children that informs 
treatment needs and the prophylactic use of iron supple-
mentation or fortification.10–13 Collecting geospatial data 
is not invasive and comparatively less costly than biolog-
ical measures, as geographical datasets are often publicly 
available on the internet. This also improves the access to 
and comparability of population-level statistics within and 
across national borders.
We previously conducted a secondary spatial analysis 
to determine the geospatial factors associated with infec-
tion status among iron deficient and sufficient children 
in rural Ghana.14 The results of these analyses suggested 
that the risk of infection may be related to elevation, 
and distance to the nearest health facility. The objective 
of the current analysis was to determine the geospatial 
factors associated with malaria and non-malaria infection 
status among Ghanaian children at the end of a 5-month 
randomised iron intervention trial.
MeThods
study population
The data used in these analyses were generated from 
a study population of young children (6–35 months of 
age) who participated in a community-based cluster-ran-
domised trial conducted in the Brong-Ahafo Region 
of Ghana in 2010.15 The trial consisted of a 5-month 
intervention period, where participants received micro-
nutrient powders with or without iron, followed by a 
1-month postintervention follow-up period (6 months in 
total). At the time of the trial, the estimated prevalence of 
malaria in Ghana was 7.2 million cases per year, and the 
prevalence of anaemia among preschool aged children 
was 76.1% (95% CI 73.9% to 78.2%).16 17 Details of the 
clinical trial15 and geographical layout of the study area 
have been described elsewhere (Aimone, Brown, Zlotkin, 
Cole, Owusu-Agyei 2016).
Measures from trial data
Biological samples collected at the beginning and end 
of the 5-month intervention period were analysed for 
plasma ferritin (Spectro Ferritin S-22, Ramco Labora-
tories, Stafford, USA), CRP (QuickRead CRP, Orion 
Diagnostica, Espoo, Finland) and malaria parasite density 
(microscopy).15 Malaria screening was also performed 
on a weekly basis throughout the intervention period. 
If a child had a history of fever (within 48 hours) or an 
axillary temperature >37.5°C, a blood sample was drawn 
and analysed in the field via antigen test (Paracheck Pf), 
and in the lab using microscopy (thin and thick smears). 
Parasite density was combined with fever information to 
calculate clinical malaria incidence (episode counts). 
Demographic and nutrition-related information was 
also collected at baseline and included household assets, 
maternal education and child body weight and length. 
Weight-for-length and length-for-age z-scores were calcu-
lated using the WHO Child Growth Standards.18
Variable preparation
Geographical coordinates for the compounds of 1943 trial 
participants (representing 1539 clusters), surrounding 
health facilities and major road networks were collected 
using handheld global positioning system (GPS) units 
(WGS 1984 coordinate system, universal transverse 
Mercator zone 30N projection, EPSG code: 32 630). Satel-
lite-derived data were downloaded as global datasets19–21 
and cropped according to the geographical boundaries 
of the trial area. Elevation had a range of 116–530 m, and 
values were centred by subtracting 250. Land cover (LC) 
type consisted of three categorical values, representing 
woody savannah (LC=8, n=21/1943 observations), 
urban and built up land (LC=13, n=243/1943 observa-
tions), and cropland/natural vegetation mosaic (LC=14, 
n=1679/1943 observations). Normalized difference vege-
tation index (NDVI), a vegetation index included as a 
proxy for moisture,22 was averaged over the year that the 
trial was conducted (2010), and ranged in value from 
0.22 to 0.62. NDVI has also been used to create malaria 
risk distribution maps through the characterisation of 
vector habitat potential (eg, closed forest versus open 
forest).23 Two NDVI-LC interaction terms were created 
(NDVI*LC8 and NDVI*LC13) by overlaying the final 
NDVI and LC rasters, and masking the LC cells except 
where they had a value of 8 (or 13). These unmasked cells 
were given a value of zero.
Baseline age, in months, was calculated using the 
reported date of birth and trial enrolment date with a 
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change point at 24 months. Household asset score was 
generated using a principal component analysis of six 
economic indicators (farm ownership, size and type of 
crops grown, type of toilet facility, and house ownership). 
Maternal education was included as a binary variable 
representing ‘no’ (0) versus ‘any’ (1) level of education. 
Baseline iron status was defined as serum ferritin concen-
tration corrected for inflammation (baseline CRP) using 
a regression-based method (Namaste, Rohner, Huang, 
Bhushan, Flores-Ayala, Kupka, Mei, Rawat, Williams, 
Raiten, Northrop-Clewes, Suchdev, Adjusting ferrith 
concentration for inflammation, 2016, unpublished), 
and re-scaled by multiplying the corrected values by the 
inter-quartile range. Straight-line (Euclidean) distance to 
the nearest health facility was measured using the Near 
Table tool in ArcMap (ArcGIS V.10.2, Environmental 
Systems Resource Institute, Redlands, California, USA).
spatial modelling
The endline data were analysed using generalized linear 
geostatistical models (GLGM)24 25 with Bayesian infer-
ence via an Integrated Nested Laplace Approximation 
algorithm.26 Weak or uninformative priors were used 
for all model parameters with the exception of the 
Matern shape parameter (fixed at two). Four different 
endline infection outcomes were modelled separately: 
1) inflammation (CRP >5 mg/L) with/without malaria 
parasitaemia; 2) inflammation (CRP >5 mg/L) without 
parasitaemia; 3) parasitaemia with measured concurrent 
fever (axillary temperature >37.5°C) or reported history 
of fever within 48 hours (ie, clinical malaria)) and 4) 
parasitaemia with or without concurrent fever or history 
of fever. All variables were binary-valued (coded as ‘1’ for 
positive infection status at endline) and analysed using 
logistic regression, with the exception of the third defini-
tion (parasitaemia with fever), which was a count variable 
(number of new clinical malaria episodes during the 
intervention period) analysed using Poisson regression. 
Median infection probabilities (and 95% credible inter-
vals, CrIs) were modelled as the sum of the contributions 
of the independent variables, residual spatial variation, 
and a compound-level random effect term. The glgm 
function from the ‘geostatsp’ package in R was used for 
all spatial modelling.27 28
The spatial analyses were conducted in three model-
ling steps: 1) No-iron group only; 2) Iron group only; 3) 
both intervention groups combined. The interventions 
groups were analysed separately in order to differentiate 
the effects of time and the iron treatment. Infection prob-
abilities from the combined-group models were plotted 
on a base map of the trial area, with study compounds, 
and major road networks. The maps depicted a spatial 
risk surface of predicted infection probabilities, which 
were computed as the posterior means of the odds or 
risk of infection. The posterior means were estimated 
assuming baseline values for individual-level covariates 
and location-specific values for spatial covariates. The 
posterior mean of the spatial random effect was also 
plotted, representing the residual spatial variation that 
corresponded to the difference between the predicted 
and expected odds or risk of infection at each location.
ethics
The original clinical trial was approved by the Kintampo 
Health Research Centre (KHRC) Institutional Ethics 
Committee, the Ghana Health Service (GHS) Ethical 
Review Committee, the Hospital for Sick Children 
Research Ethics Board and the Food and Drugs Authority 
of Ghana. Approval for conducting the secondary anal-
yses was obtained from the Hospital for Sick Children and 
University of Toronto Health Sciences Research Ethics 
Boards.
resulTs
Baseline and endline characteristics of the study sample 
are presented in table 1. A total of 1780 trial participants 
were included in the endline analyses, representing those 
with geocoded residences (compounds), who provided 
blood samples at endline and had both baseline and 
endline CRP and parasitaemia values (see online supple-
mentary figure 1). For the infection outcome defined 
as parasitaemia with fever, there were 1939 observa-
tions included in the Poisson regression analysis, which 
corresponded to the number of children with geocoded 
compounds who had at least one recorded follow-up visit 
during the intervention period, and thus contributed 
data to the malaria count outcome.
The proportion of children with evidence of infection 
(elevated CRP and/or parasitaemia) increased from base-
line to endline (37.0% at baseline vs 41.6% at endline). 
This increase may have been driven primarily by a greater 
prevalence of parasitaemia at endline (27.1% vs 23.0% 
at baseline), though the difference between intervention 
groups was small (26.3% vs 28.0% in the No-iron and 
Iron groups, respectively). The prevalence of non-ma-
laria inflammation (CRP >5 mg/L without parasitaemia) 
remained relatively stable over the course of the trial; 
however, the proportion in the Iron group was slightly 
higher at endline (7.64% in the Iron group versus 6.58% 
in the No-iron group). After correcting ferritin concen-
tration for inflammation (CRP) using the regression 
method, the prevalence of iron deficiency (ferritin <12 
µg/L) was 25.5% (496/1943) at baseline and 12.7% 
(226/1781) at endline (95/886 in the Iron group, 
131/895 in the No-iron group).
In the combined-group analyses, the risk of elevated 
CRP and/or parasitaemia at endline was negatively associ-
ated with household asset score and positively associated 
with baseline infection status (OR for definition 1: 0.88, 
95% CrI 0.78 to 0.98) (table 2). Baseline infection status 
was also significantly and positively associated with the 
corresponding endline outcome when defined as inflam-
mation and/or parasitaemia (OR 1.84, 95% CrI 1.36 to 
2.50) or all parasitaemia (2.75, 95% CrI 1.91 to 3.95). 
Although not statistically significant, the effect of the 
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‘Group’ variable seemed to suggest that the iron interven-
tion was positively associated with endline infection risk, 
except in the case of outcome definition 3 (parasitaemia 
with fever) where the iron treatment may have had a 
protective effect.
Results from the by-group analyses indicated that the 
risk of elevated CRP (without parasitaemia) at endline 
among children in the No-iron group was positively 
associated with baseline weight-for-length z-score (OR 
1.30, 95% CrI 1.06 to 1.60) and negatively associated 
with age between 24 and 36 months (OR 0.92, 95% CrI 
0.84 to 1.006). When infection was defined as all para-
sitaemia, baseline infection status became a significant 
factor (OR for definition 4: 2.86, 95% CrI 1.97 to 4.17), 
indicating that children in the No-iron group with any 
parasitaemia (with or without CRP or fever) at baseline 
were up to 186% more likely to have parasitaemia at 
endline (see online supplementary table 1). In the Iron 
group, when infection was defined as inflammation and/
or parasitaemia, baseline infection status was the only 
factor associated with infection risk at endline (OR 2.27, 
95% CrI 1.66 to 3.11). Similar results were found when 
infection was defined as all parasitaemia (OR 2.54, 95% 
CrI 1.75 to 3.68) (see online supplementary table 2).
Plots of the predicted risk and residual spatial varia-
tion from all combined-group models are illustrated in 
figure 1. The maps show a defined low-risk area around the 
District centre, regardless of how infection was defined. 
Conversely, the location of high-risk areas seemed to vary 
across models and, in some cases, roughly approximated 
elevation (figure 2). The maps depicting residual spatial 
variation also show defined high-risk and low-risk areas, 
indicating that a large amount of spatial variation was not 
explained by the variables included in the analyses and 
further supported the significant spatial random effects 
observed across all models.
discussion
The analyses presented herein explored the geospatial 
variation and associated factors of infection, defined using 
both inflammatory and parasitic biomarkers, among chil-
dren in a malaria endemic area (rural Ghana) after a 
randomised iron intervention trial. Although none of the 
Table 1 Baseline and endline characteristics of the Ghana trial participants
Baseline Endline
Trial participants with a geocoded residence (n)
Males (%)
Age at enrolment (months), mean (SD)*
Serum ferritin (µg/L), geometric mean (SD)
Parasite density (count/µL), geometric mean (SD)
C-reactive protein (mg/L), mean (SD)
1943
992 (51.1)
19.2 (8.5)
35.1 (3.65)
3003.0 (5.35)
3.34 (4.96)
1780
900 (50.5)
19.3 (8.5)
73.9 (3.58)
4160.4 (6.30)
3.86 (5.10)
Infection status
Inflammation without parasitaemia†, n (%)
Inflammation and/or parasitaemia‡, n (%)
Parasitaemia with fever§¶ n (%)
All parasitaemia**, n (%)
272 (14.0)
719 (37.0)
150 (7.72)
447 (23.0)
258 (14.5)
741 (41.6)
555 (28.6)
483 (27.1)
Anthropometric status††
Weight-for-length z-score, mean (SD)
Length-for-age z-score, mean (SD)
−0.63 (0.97)
−0.81 (1.21)
−0.62 (0.97)
−0.80 (1.29)
Maternal Education, n (%)‡‡
None
Any
586 (33.5)
1166 (66.5)
543 (33.0)
1105 (67.0)
Household Asset Score, n (%)§§
Low
High
900 (49.0)
938 (51.0)
817 (47.7)
897 (52.3)
*Measured at baseline only.
†Inflammation without parasitaemia (n=1780) = CRP >5 mg/L without malaria parasitaemia.
‡Inflammation and/or parasitaemia (n=1780) = CRP >5 mg/L and/or any malaria parasitaemia.
§Parasitaemia with fever (n=1939) = any malaria parasitaemia with concurrent fever (axillary temperature >37.5°C) or history of reported fever 
(within 48 hours).
¶Endline value represents the period prevalence for 1939 participants.
**All parasitaemia (n=1780) = any malaria parasitaemia (with/without fever).
††Measured at baseline; z-scores estimated using the WHO Child Growth Standards.23
‡‡Measured at baseline only; total n=1752 (74 respondents were not mothers, 117 missing due to incomplete surveys).
§§Measured at baseline only; Low= below median, High = above median; reduced sample size (approximately 1825) due to incomplete 
surveys and ‘unknown’ responses.
CRP, C-reactive protein.
 5Aimone AM, et al. BMJ Open 2017;7:e013192. doi:10.1136/bmjopen-2016-013192
Open Access
Ta
b
le
 2
 
G
eo
sp
at
ia
l a
nd
 n
on
-s
p
at
ia
l r
is
k 
fa
ct
or
s 
of
 e
nd
lin
e 
in
fe
ct
io
n 
st
at
us
†  
am
on
g 
G
ha
na
ia
n 
ch
ild
re
n 
in
 t
he
 c
om
b
in
ed
 Ir
on
 a
nd
 N
o-
iro
n 
gr
ou
p
s 
(B
ro
ng
-A
ha
fo
 R
eg
io
n 
20
10
)
C
o
va
ri
at
es
E
st
im
at
e 
(9
5%
 C
rI
) o
n 
th
e 
ex
p
o
ne
nt
ia
l 
sc
al
e‡
R
an
g
e 
p
ar
am
et
er
 in
 
km
 (9
5%
 C
rI
)
S
D
 o
f 
ra
nd
o
m
 e
ff
ec
ts
 (9
5%
 C
rI
)
S
p
at
ia
l
C
om
p
ou
nd
O
ut
co
m
e 
1:
 In
fla
m
m
at
io
n 
an
d
/o
r 
p
ar
as
ita
em
ia
 (n
=
17
80
)
In
te
rc
ep
t
A
ge
 p
er
 m
on
th
6–
23
 m
on
th
s
24
–3
5 
m
on
th
s
S
ex
 (m
al
e 
re
fe
re
nc
e)
Le
ng
th
-f
or
-a
ge
 z
-s
co
re
W
ei
gh
t-
fo
r-
le
ng
th
 z
-s
co
re
A
ss
et
 s
co
re
D
is
ta
nc
e 
to
 h
ea
lth
 fa
ci
lit
y 
(k
m
)
E
le
va
tio
n 
(m
)
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
*G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
*G
ro
up
0.
58
9 
1.
00
4
1.
00
0
1.
08
7
0.
98
2
1.
08
8
0.
87
5
1.
03
4
0.
99
6
1.
84
3
1.
09
4
1.
06
8
1.
19
2
0.
98
3
(0
.3
37
 t
o 
1.
07
2)
 
(0
.9
84
 t
o 
1.
02
6)
(0
.9
62
 t
o 
1.
03
8)
(0
.8
86
 t
o 
1.
33
3)
(0
.8
96
 t
o 
1.
07
5)
(0
.9
78
 t
o 
1.
21
1)
(0
.7
79
 t
o 
0.
98
0)
*
(0
.9
33
 t
o 
1.
13
6)
(0
.9
91
 t
o 
1.
00
1)
(1
.3
59
 t
o 
2.
50
0)
*
(0
.8
26
 t
o 
1.
44
8)
(0
.9
56
 t
o 
1.
19
4)
(0
.7
75
 t
o 
1.
83
3)
(0
.8
47
 t
o 
1.
14
4)
7.
34
1 
(2
.9
28
 t
o 
15
.8
4)
0.
52
5 
(0
.3
06
 t
o 
0.
94
4)
0.
00
8 
(0
.0
04
 t
o 
0.
02
9)
O
ut
co
m
e 
2:
 In
fla
m
m
at
io
n 
w
ith
ou
t 
p
ar
as
ita
em
ia
 (n
=
17
80
)
In
te
rc
ep
t
A
ge
 p
er
 m
on
th
6-
23
 m
on
th
s
24
-3
5 
m
on
th
s
S
ex
 (m
al
e 
re
fe
re
nc
e)
Le
ng
th
-f
or
-a
ge
 z
-s
co
re
W
ei
gh
t-
fo
r-
le
ng
th
 z
-s
co
re
A
ss
et
 s
co
re
D
is
ta
nc
e 
to
 h
ea
lth
 fa
ci
lit
y 
(k
m
)
E
le
va
tio
n 
(m
)
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
*G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
*G
ro
up
0.
18
3 
1.
00
9
0.
95
6
1.
13
9
1.
09
2
1.
05
4
0.
87
1
1.
01
2
0.
99
9
1.
05
5
1.
00
9
1.
00
1
1.
52
3
1.
03
3
(0
.1
06
 t
o 
0.
30
9)
* 
(0
.9
82
 t
o 
1.
03
8)
(0
.9
04
 t
o 
1.
00
9)
(0
.8
65
 t
o 
1.
50
2)
(0
.9
68
 t
o 
1.
23
0)
(0
.9
12
 t
o 
1.
21
7)
(0
.7
50
 t
o 
1.
01
0)
(0
.9
24
 t
o 
1.
09
3)
(0
.9
94
 t
o 
1.
00
3)
(0
.5
74
 t
o 
1.
82
6)
(0
.7
13
 t
o 
1.
42
7)
(0
.8
44
 t
o 
1.
15
6)
(0
.7
18
 t
o 
3.
30
0)
(0
.8
56
 t
o 
1.
26
1)
10
.7
7 
(8
.7
67
 t
o 
25
.5
4)
0.
40
7 
(0
.2
08
 t
o 
0.
83
0)
0.
00
7 
(0
.0
04
 t
o 
0.
02
8)
O
ut
co
m
e 
3:
 P
ar
as
ita
em
ia
 w
ith
 fe
ve
r 
(n
=
19
39
)
C
on
tin
ue
d
6 Aimone AM, et al. BMJ Open 2017;7:e013192. doi:10.1136/bmjopen-2016-013192
Open Access 
C
o
va
ri
at
es
E
st
im
at
e 
(9
5%
 C
rI
) o
n 
th
e 
ex
p
o
ne
nt
ia
l 
sc
al
e‡
R
an
g
e 
p
ar
am
et
er
 in
 
km
 (9
5%
 C
rI
)
S
D
 o
f 
ra
nd
o
m
 e
ff
ec
ts
 (9
5%
 C
rI
)
In
te
rc
ep
t
A
ge
 p
er
 m
on
th
6-
23
 m
on
th
s
24
-3
5 
m
on
th
s
S
ex
 (m
al
e 
re
fe
re
nc
e)
Le
ng
th
-f
or
-a
ge
 z
-s
co
re
W
ei
gh
t-
fo
r-
le
ng
th
 z
-s
co
re
A
ss
et
 s
co
re
D
is
ta
nc
e 
to
 h
ea
lth
 fa
ci
lit
y 
(k
m
)
E
le
va
tio
n 
(m
)
G
ro
up
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
B
as
el
in
e 
iro
n 
st
at
us
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
*G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
*G
ro
up
0.
00
3 
1.
00
8
0.
97
8
0.
93
9
0.
99
2
0.
96
6
1.
02
9
1.
05
7
0.
99
7
0.
89
1
0.
73
0
1.
02
8
1.
20
9
0.
95
4
(0
.0
02
 t
o 
0.
00
4)
* 
(0
.9
91
 t
o 
1.
02
5)
(0
.9
48
 t
o 
1.
00
8)
(0
.7
99
 t
o 
1.
10
4)
(0
.9
23
 t
o 
1.
06
4)
(0
.8
86
 t
o 
1.
05
3)
(0
.9
37
 t
o 
1.
13
0)
(0
.9
72
 t
o 
1.
14
9)
(0
.9
93
 t
o 
1.
00
2)
(0
.7
29
 t
o 
1.
08
7)
(0
.4
52
 t
o 
1.
11
4)
(0
.9
42
 t
o 
1.
11
2)
(0
.6
39
 t
o 
2.
28
2)
(0
.8
49
 t
o 
1.
06
9)
7.
36
5 
(3
.2
25
 t
o 
15
.1
8)
0.
46
4 
(0
.2
73
 t
o 
0.
82
5)
0.
00
7 
(0
.0
04
 t
o 
0.
02
8)
O
ut
co
m
e 
4:
 A
ll 
p
ar
as
ita
em
ia
 (n
=
17
80
)
In
te
rc
ep
t
A
ge
 p
er
 m
on
th
6–
23
 m
on
th
s
24
–3
5 
m
on
th
s
S
ex
 (m
al
e 
re
fe
re
nc
e)
Le
ng
th
-f
or
-a
ge
 z
-s
co
re
W
ei
gh
t-
fo
r-
le
ng
th
 z
-s
co
re
A
ss
et
 s
co
re
D
is
ta
nc
e 
to
 h
ea
lth
 fa
ci
lit
y 
(k
m
)
E
le
va
tio
n 
(m
)
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
B
as
el
in
e 
in
fe
ct
io
n 
st
at
us
*G
ro
up
B
as
el
in
e 
iro
n 
st
at
us
*G
ro
up
0.
27
1 
0.
99
3
1.
02
2
1.
02
4
0.
92
6
1.
06
8
0.
91
6
1.
02
2
0.
99
6
2.
74
6
1.
16
9
1.
06
1
0.
91
5
0.
98
0
(0
.1
35
 t
o 
0.
57
1)
* 
(0
.9
66
 t
o 
1.
02
1)
(0
.9
94
 t
o 
1.
05
0)
(0
.8
14
 t
o 
1.
28
7)
(0
.8
35
 t
o 
1.
02
6)
(0
.9
47
 t
o 
1.
20
4)
(0
.8
02
 t
o 
1.
04
4)
(0
.9
02
 t
o 
1.
16
4)
(0
.9
90
 t
o 
1.
00
3)
(1
.9
10
 t
o 
3.
95
1)
*
(0
.8
62
 t
o 
1.
58
7)
(0
.9
40
 t
o 
1.
19
3)
(0
.5
55
 t
o 
1.
50
8)
(0
.8
39
 t
o 
1.
14
5)
7.
84
6 
(3
.3
84
 t
o 
16
.0
6)
0.
71
2 
(0
.4
06
 t
o 
1.
29
1)
0.
00
8 
(0
.0
04
 t
o 
0.
02
9)
Ta
b
le
 2
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 7Aimone AM, et al. BMJ Open 2017;7:e013192. doi:10.1136/bmjopen-2016-013192
Open Access
spatial variables included in the by-group or combined-
group models demonstrated significant associations with 
endline infection status (regardless of how infection was 
defined), the plots of predicted infection probabilities 
and spatial random effects showed defined high-risk and 
low-risk areas across the study region, particularly around 
the District centre. In terms of individual-level effects, 
baseline infection status was a consistent predictor of 
endline infection risk, particularly in the Iron group and 
when infection was defined using parasitaemia (with or 
without inflammation).
The consistency of the relationship with baseline 
parasitaemia in both intervention groups is somewhat 
surprising, as current evidence might lead one to expect 
that providing iron to children with malaria would 
increase their risk of subsequent parasitic infections to a 
greater extent than those who do not receive iron.8 Inter-
estingly, the Iron group analyses also revealed a significant 
effect of baseline infection status when acute non-ma-
laria inflammation (high CRP without parasitaemia) was 
included in the definition. This observation is supported 
by recent research in mice demonstrating that iron 
supplementation may exacerbate non-malaria bacterial 
infections, and that coinfection with Plasmodium yoelli and 
Salmonella typhimurium can produce overwhelming Salmo-
nella sepsis.29 Findings from the current analyses that also 
suggested a potential adverse effect of the iron interven-
tion were the positive group effects across all infection 
definitions with the exception of clinical malaria (parasi-
taemia with fever). It should be noted, however, that these 
were non-significant associations only. This discrepancy is 
likely related to the fact that all children in both groups 
were monitored and treated for identified clinical malaria 
episodes throughout the intervention period. Therefore, 
any cases of asymptomatic malaria (parasitaemia without 
fever) may have persisted over the course of the trial, 
potentially interacting with the iron intervention as well 
as other opportunistic non-malaria infections.
After stratifying the analyses by group, we found that chil-
dren in the No-iron group with a higher weight-for-length 
z-score (a measure of nutritional status) at baseline were 
30% more likely to have high CRP (>5 mg/L) at endline 
(OR 1.30, 95% CrI 1.06 to 1.60) (see online supplemen-
tary table 1). This positive association was not expected, 
given that well-nourished children (those with higher 
weight-length z-scores) are expected have a lower risk of 
infection.4 Since CRP becomes elevated during the first 
48 hours of the inflammatory response,30 it is unlikely 
that anthropometric measures at baseline influenced 
inflammatory status 5 months later at endline. Rather, it 
is more likely that the association was influenced through 
another unmeasured factor, such as immune function. 
High CRP was also inversely associated with age in the 
No-iron group for children between 24 and 36 months 
(OR 0.92, 95% CrI (0.84 to 1.00)), indicating an 8% lower 
odds of elevated CRP at endline for every month of age 
older. Assuming that elevated CRP without parasitaemia 
represented acute non-malaria infection, it is plausible C
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that the inverse relationship reflected the development 
of the immune system with age, thus resulting in older 
children being more resilient to infection exposure.
In the combined-group models (table 2), higher asset 
score was associated with a 12% decreased odds of endline 
infection, defined as CRP >5 mg/L and/or parasitaemia 
(OR 0.88, 95% CrI 0.78 to 0.98), suggesting that children 
from wealthier households had a lower risk of malaria or 
non-malaria infection at endline (regardless of whether 
they received micronutrient powders (MNPs) with or 
without iron). This finding was not surprising given the 
well-documented association between household wealth 
and child health in low-income and middle-income 
settings;31 however, the inconsistency of this relationship 
across infection definitions may have been a reflection 
of other socioeconomic or behavioural factors that were 
not included in the analyses.32 Despite any differences 
in (or lack of) variable associations across infection 
outcomes, the residual spatial variation in infection risk 
remained significant in all combined-group models. The 
importance of accounting for residual spatial variation 
was further illustrated when the spatial random effects 
were plotted. For example, when infection was defined 
using CRP only, the model output plots looked similar 
(figure 1B), suggesting that the spatial random effect 
encompassed a large amount of the variation in predicted 
risk, while the variables included in the model did not.
For the infection outcomes that included parasitaemia, 
we observed similarities between the geographical vari-
ation in predicted mean risk and elevation (figure 2). 
This finding is consistent with our baseline analyses14 
as well as other studies conducted in malaria endemic 
areas, where a higher prevalence of malaria is observed 
among populations living at lower elevations and vice 
versa.33–36 The association between malaria and elevation 
is related to temperature, as the early stages of para-
site development are inhibited in colder environments, 
which are found at higher altitudes.37 Our baseline anal-
yses also demonstrated a significant effect of distance to 
the nearest health facility, indicating that those children 
living farther from a health facility had an increased risk 
of malaria parasitaemia at baseline. The current endline 
analyses also suggested a potential risk-enhancing effect 
of distance to a health facility across all infection defini-
tions, although the effect was not significant. This trend 
was further supported by the model output plots, which 
Figure 1 Predicted probabilities (left) and residual spatial variation (right) from the final combined-group models for the odds 
of inflammation (CRP>5 mg/L) and/or any malaria parasitaemia (A); the odds of inflammation (CRP > 5 mg/L) without malaria 
parasitaemia (B); the risk of malaria parasitaemia with concurrent fever (axillary temperature >37.5°C—or history of reported 
fever within 48 hours) (C) and the odds of malaria parasitaemia with or without fever (D). Darker colour indicates higher risk at 
endline. Background © Stamen Design.
Figure 2 Elevation (metres) across the study area. Green 
colour indicates higher elevation.
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demonstrated larger low-risk areas around villages, and 
particularly around the District centre. Other studies 
have shown that living in a capital or municipal centre is 
associated with a reduced risk of adverse infection-related 
or nutrition-related health outcomes,38 39 likely due to 
increased access to healthcare services and social ameni-
ties.
Overall, it appears that the effect of the intervention 
may have diminished the spatial associations observed at 
baseline; however, with the current data, it is difficult to 
differentiate between the effects of the iron intervention 
itself and the trial-related malaria mitigation activities 
(eg, universal provision of treated bed nets, and malaria 
treatment when indicated). Further research involving 
additional secondary analyses with expanded spatial data-
sets40 could shed more light on these relationships as well 
as their implications on the safety of iron interventions 
in malaria endemic areas. Until that time, the potential 
utility of geospatial analysis lies primarily in the assess-
ment or planning stages of micronutrient programmes, 
in terms of where malaria and/or non-malaria infection 
risk is likely a concern, and thus where infection control 
efforts should be focused if iron fortification or supple-
mentation is to be implemented.
A potential limitation of the present analyses was the 
use of straight-line (Euclidean) distance for estimating 
proximity to a health facility. While distance by road may 
have been a more appropriate indicator of travel imped-
ance or access, incomplete or missing vector information 
(eg, miss-aligned junctions, missing or disconnected 
road segments) made it difficult to generate accurate 
measures. Nesbitt and colleagues (2014) compared 
different measures of travel impedance to estimate access 
to delivery care in the Brong-Ahafo region of Ghana41 and 
concluded that straight-line distance was as informative as 
distance by road for determining spatial access in rural 
Ghana. Therefore, we felt it was justified to use Euclidean 
distance in the present analyses.
Non-malaria infections were identified using CRP, an 
acute phase protein that rises in accordance with the 
early phase of the inflammatory response (approximately 
48 hours). Other acute phase proteins (such as alpha-1-
acid glycoprotein) reach their peak concentration during 
the late phase (approximately 2–8 days), which more 
closely approximates the change in ferritin concentration 
in response to inflammation.30 Since CRP was the only 
inflammatory biomarker available for the current anal-
ysis, and the original trial protocol was not designed to 
include diagnoses of other infection types, it is possible 
that the prevalence of non-malaria infection among 
participants was underestimated.
conclusion
The analyses presented herein explored the spatial 
dynamics of infection risk in the context of an iron 
intervention trial in a malaria endemic area among 
children with varying levels of iron status, where all 
children received bed nets and access to malaria treat-
ment. Geographical variation in the risk of malaria and 
non-malaria infections was observed with distinct high-
risk and low-risk areas, particularly around the District 
centre. Overall, our findings emphasize the importance 
of considering geographical distribution when assessing 
infection risk and planning intervention trials in LMIC 
paediatric populations.
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